Oxygen Sensors and P450 Monooxygenases in Mycobacertium tuberculosis

结核分枝杆菌中的氧传感器和 P450 单加氧酶

基本信息

项目摘要

DESCRIPTION (provided by applicant): The three greatest current needs for progress in the treatment of tuberculosis are to (a) develop drugs against drug resistant strains of Mycobacterium tuberculosis, (b) develop effective approaches to treat the latent states of the disease, and (c) shorten the course of therapy, which is related to the second goal. Here we propose to characterize the DevS/DosR and the redundant DosT/DosR two-component regulatory systems of M. tuberculosis. These regulatory systems control a panel of approximately 50 genes that is induced by low oxygen concentrations or NO exposure. The anaerobic state of M. tuberculosis is thought to resemble (but not be identical to) that found in latent infections and serves as model for it. We have found that the DevS and DosT sensor kinases have a heme group in their sensory domain and will investigate the structure of these sensors, their sensitivity to O2, CO, and NO, and the mechanisms that link binding of a gas to the heme group with autophosphorylation of a histidine residue in the kinase. A high-throughput screen will be performed to identify inhibitors of the DevS / DosT kinases, as inhibitors offer a possible route to treatment of the latent disease. Determination of structure-activity profiles and optimization of the inhibitors will be pursued. In a related but distinct effort, we propose to clone, express, and characterize the P450 enzyme complement of M. tuberculosis. Clinically used azole drugs that target P450 enzymes in fungi attenuate mycobacterial growth even in the latent state, but the substrates and biological roles of the twenty M. tuberculosis P450 enzymes are not known. Two of the P450 enzymes have been described in the literature, and we already have three further members of this M. tuberculosis family in hand. Each enzyme will be characterized by spectroscopic and crystallographic methods, and its affinity for azole drugs will be determined. A search for the relevant substrates for each enzyme will be pursued using a variety of techniques. The role of the P450 enzymes will also be investigated by individually disrupting ("knocking out") each P450 enzyme in M. tuberculosis. The consequences of each P450 enzyme disruption will be analyzed by DNA microarray studies in addition to determination of the associated changes in bacterial growth and virulence. The project thus encompasses two heme- and oxygen-dependent system of M. tuberculosis that offer new avenues to the development of drugs effective against the latent form of the disease.
描述(由申请人提供):目前对结核病治疗进展的三个最大需求是(a)开发针对结核分枝杆菌耐药菌株的药物,(B)开发治疗疾病潜伏状态的有效方法,以及(c)缩短疗程,这与第二个目标有关。在这里,我们提出了表征的DevS/DosR和冗余的DosT/DosR双组分调节系统的M。结核这些调控系统控制着一组由低氧浓度或NO暴露诱导的约50个基因。M.结核病被认为类似于我们已经发现DevS和DoS T传感器激酶在其感觉域中具有血红素基团,并且将研究这些传感器的结构,它们对O2、CO和NO的敏感性,以及将气体与血红素基团的结合与激酶中组氨酸残基的自磷酸化联系起来的机制。将进行高通量筛选以鉴定DevS / DosT激酶的抑制剂,因为抑制剂提供了治疗潜伏性疾病的可能途径。将继续进行抑制剂的构效关系测定和优化。在一个相关的,但不同的努力,我们建议克隆,表达和表征的P450酶补体的M。结核临床上使用的靶向真菌中P450酶的唑类药物即使在潜伏状态下也能减弱分枝杆菌的生长,但20种M.结核病P450酶未知。文献中描述了两种P450酶,我们已经有了这种M.肺结核家族在手上每种酶将通过光谱和晶体学方法进行表征,并确定其对唑类药物的亲和力。将使用各种技术来寻找每种酶的相关底物。P450酶的作用也将通过单独破坏(“敲除”)M中的每种P450酶来研究。结核除了确定细菌生长和毒力的相关变化外,还将通过DNA微阵列研究分析每种P450酶破坏的后果。因此,该项目包括两个血红素和氧依赖系统的M。结核病,为开发有效对抗潜伏形式的疾病的药物提供了新的途径。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Paul R Ortiz De Montellano其他文献

Paul R Ortiz De Montellano的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Paul R Ortiz De Montellano', 18)}}的其他基金

MECHANISMS AND INACTIVATION OF HEMOPROTEINS
血蛋白的机制和失活
  • 批准号:
    8363721
  • 财政年份:
    2011
  • 资助金额:
    $ 40.69万
  • 项目类别:
LIPIDOMIC ANALYSIS OF MYCOBACTERIUM TUBERCULOSIS
结核分枝杆菌的脂质组学分析
  • 批准号:
    8363790
  • 财政年份:
    2011
  • 资助金额:
    $ 40.69万
  • 项目类别:
ROLE OF CYS RESIDUES AS A THIOL/DISULFIDE SWITCH IN HEME OXYGENASE 2 PROTEIN
半胱氨酸残基作为血红素加氧酶 2 蛋白中硫醇/二硫键开关的作用
  • 批准号:
    8363844
  • 财政年份:
    2011
  • 资助金额:
    $ 40.69万
  • 项目类别:
UNNATURAL AMINO ACID INCORPORATION INTO PROTEINS AND QUANTIFICATION THEROF
非天然氨基酸掺入蛋白质及其定量
  • 批准号:
    8363805
  • 财政年份:
    2011
  • 资助金额:
    $ 40.69万
  • 项目类别:
UNNATURAL AMINO ACID INCORPORATION INTO PROTEINS AND QUANTIFICATION THEROF
非天然氨基酸掺入蛋白质及其定量
  • 批准号:
    8169801
  • 财政年份:
    2010
  • 资助金额:
    $ 40.69万
  • 项目类别:
MECHANISMS AND INACTIVATION OF HEMOPROTEINS
血蛋白的机制和失活
  • 批准号:
    8169716
  • 财政年份:
    2010
  • 资助金额:
    $ 40.69万
  • 项目类别:
LIPIDOMIC ANALYSIS OF MYCOBACTERIUM TUBERCULOSIS
结核分枝杆菌的脂质组学分析
  • 批准号:
    8169785
  • 财政年份:
    2010
  • 资助金额:
    $ 40.69万
  • 项目类别:
UNNATURAL AMINO ACID INCORPORATION INTO PROTEINS AND QUANTIFICATION THEROF
非天然氨基酸掺入蛋白质及其定量
  • 批准号:
    7957406
  • 财政年份:
    2009
  • 资助金额:
    $ 40.69万
  • 项目类别:
LIPIDOMIC ANALYSIS OF MYCOBACTERIUM TUBERCULOSIS
结核分枝杆菌的脂质组学分析
  • 批准号:
    7957425
  • 财政年份:
    2009
  • 资助金额:
    $ 40.69万
  • 项目类别:
MECHANISMS AND INACTIVATION OF HEMOPROTEINS
血蛋白的机制和失活
  • 批准号:
    7724145
  • 财政年份:
    2008
  • 资助金额:
    $ 40.69万
  • 项目类别:

相似海外基金

Developing Late Metal Catalytic Systems for Aerobic Partial Oxidation of Alkanes
开发烷烃有氧部分氧化的后金属催化系统
  • 批准号:
    2247667
  • 财政年份:
    2023
  • 资助金额:
    $ 40.69万
  • 项目类别:
    Standard Grant
Targeting aerobic glycolysis via hexokinase 2 inhibition in Natural Killer T cell lymphomas
通过抑制己糖激酶 2 靶向自然杀伤 T 细胞淋巴瘤中的有氧糖酵解
  • 批准号:
    23K07830
  • 财政年份:
    2023
  • 资助金额:
    $ 40.69万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Precision Medicine in Alzheimer’s Disease: A SMART Trial of Adaptive Exercises and Their Mechanisms of Action Using AT(N) Biomarkers to Optimize Aerobic-Fitness Responses
阿尔茨海默病的精准医学:使用 AT(N) 生物标志物优化有氧健身反应的适应性运动及其作用机制的 SMART 试验
  • 批准号:
    10581973
  • 财政年份:
    2023
  • 资助金额:
    $ 40.69万
  • 项目类别:
MIND Foods and Aerobic Training in Black Adults with HTN: An ADRD Prevention Pilot RCT (MAT)
MIND 食品和患有 HTN 的黑人成人的有氧训练:ADRD 预防试点随机对照试验 (MAT)
  • 批准号:
    10585366
  • 财政年份:
    2023
  • 资助金额:
    $ 40.69万
  • 项目类别:
Concurrent Aerobic Exercise and Cognitive Training to Prevent Alzheimer's in at-risk Older Adults
同时进行有氧运动和认知训练可预防高危老年人的阿尔茨海默病
  • 批准号:
    10696409
  • 财政年份:
    2023
  • 资助金额:
    $ 40.69万
  • 项目类别:
Investigating the physical and chemical controls on aerobic methane oxidation
研究好氧甲烷氧化的物理和化学控制
  • 批准号:
    2241873
  • 财政年份:
    2023
  • 资助金额:
    $ 40.69万
  • 项目类别:
    Standard Grant
Effect of aerobic exercise-induced sleep changes on arterial stiffness associated with postprandial hyperglycemia.
有氧运动引起的睡眠变化对与餐后高血糖相关的动脉僵硬度的影响。
  • 批准号:
    23K10645
  • 财政年份:
    2023
  • 资助金额:
    $ 40.69万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Pro-Resolving Inflammatory Mediators in Neurovascular Gains in Aerobic Training; a phase 2, double-blind, randomized placebo-controlled trial (PRIMiNG-AT2)
有氧训练中促进神经血管增益的炎症介质的消除;
  • 批准号:
    485524
  • 财政年份:
    2023
  • 资助金额:
    $ 40.69万
  • 项目类别:
    Operating Grants
Regulators of Photoreceptor Aerobic Glycolysis in Retinal Health and Disease
视网膜健康和疾病中光感受器有氧糖酵解的调节因子
  • 批准号:
    10717825
  • 财政年份:
    2023
  • 资助金额:
    $ 40.69万
  • 项目类别:
The Effects of Aerobic Exercise on Cardiovascular Health in Postmenopausal Females: A Systematic Review and Meta-Analysis
有氧运动对绝经后女性心血管健康的影响:系统评价和荟萃分析
  • 批准号:
    480729
  • 财政年份:
    2023
  • 资助金额:
    $ 40.69万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了